A Real-world Study: Analysis of the Efficacy of Antiviral Therapy in CHB Patients Over 30 Years Old, HBV DNA Positive and ALT Normal
NCT07637214 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2026-06-09
Summary
This is a prospective observational study of CHB patients who have not received antiviral treatment but HBV DNA are positive.Investigators aim to explore the antiviral effect and influencing factors of patients over 30 years old with normal ALT level after receiving antiviral treatment.
Conditions
- Hepatitis B
- Chronic
- Treatment
Sponsors & Collaborators
-
Tongji Hospital
lead OTHER
Principal Investigators
-
Meifang Han, Doctor · Tongji Hospital
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-13
- Primary Completion
- 2024-03-13
- Completion
- 2025-06-13
Countries
- China
Study Locations
More Related Trials
-
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Real-world Study Optimizing Nucleotide-analogues
NCT05937178 ·Status: RECRUITING
-
Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients
NCT03777969 ·Status: ACTIVE_NOT_RECRUITING
-
Optimization of Antiviral Therapy of Chronic HBV Infection
NCT01623778 ·Status: COMPLETED
-
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
NCT02883647 ·Status: RECRUITING
-
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients
NCT00441974 ·Status: COMPLETED ·Phase: PHASE4
-
ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)
NCT07741461 ·Status: RECRUITING ·Phase: PHASE1
-
A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B
NCT07555340 ·Status: ACTIVE_NOT_RECRUITING
-
Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy
NCT02791386 ·Status: COMPLETED
-
Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
NCT07146100 ·Status: RECRUITING
-
Observational Study on Patients With Chronic Hepatitis B
NCT02167503 ·Status: UNKNOWN
-
Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B
NCT01533051 ·Status: UNKNOWN
-
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
NCT03753074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00324961 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B
NCT05705141 ·Status: NOT_YET_RECRUITING
-
Antiviral Therapy for Patients With Chronic Hepatitis B Infection
NCT05382351 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of BW-20507 in Chinese Healthy Subjects and Subjects With Chronic Hepatitis B
NCT07595159 ·Status: COMPLETED ·Phase: PHASE1
-
Plasma Purification and Chronic Hepatitis B
NCT04518553 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
NCT06777173 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Biomarkers Guided Stopping NAs Treatment
NCT04519359 ·Status: UNKNOWN ·Phase: NA
-
Prospective Evaluation of a Fast-track Treatment Pathway for Patients With Chronic Hepatitis B Under Primary Care
NCT04904900 ·Status: RECRUITING
-
A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)
NCT02327416 ·Status: UNKNOWN ·Phase: PHASE3
-
Real World Study of Chronic Viral Hepatitis
NCT04025944 ·Status: RECRUITING
-
Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients
NCT04724785 ·Status: UNKNOWN
-
HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg
NCT03405597 ·Status: UNKNOWN ·Phase: PHASE3